Contreras R, Ferreccio C, Sotomayor V, Astroza L, Berríos G, Ortiz E, Palomino C, Prenzel I, Pinto M E, Levine M
Programa de Control de Fiebre Tifoidea, Ministerio de Salud, Chile, Santiago.
Rev Med Chil. 1992 Feb;120(2):134-41.
The clinical course of infection by Salmonellae was compared between patients who had been vaccinated against typhoid fever using the Ty21a vaccine and those who had not. Of 2566 bacteriological confirmed cases 84% were infected with S typhi, 14% with S paratyphi B and 2% with S paratyphi A. Among patients with typhoid fever, 34% were treated in hospital, 3.5% had relapses, 5.4% developed complications and 1 patient died (0.05%). Among patients with paratyphoid fever, 18% were treated in hospital, 0.6% had relapses, 1.4% developed complications and there were no deaths. These figures were similar among vaccinated and non-vaccinated cases. A slightly greater proportion of vaccinated cases were treated in hospital (38 vs 30%). Thus, use of oral vaccination against typhoid fever does not alter the clinical course of infection with Salmonellae.
对使用Ty21a疫苗接种伤寒疫苗的患者和未接种疫苗的患者感染沙门氏菌的临床病程进行了比较。在2566例细菌学确诊病例中,84%感染伤寒杆菌,14%感染副伤寒乙杆菌,2%感染副伤寒甲杆菌。在伤寒患者中,34%住院治疗,3.5%复发,5.4%出现并发症,1例死亡(0.05%)。在副伤寒患者中,18%住院治疗,0.6%复发,1.4%出现并发症,无死亡病例。接种疫苗和未接种疫苗的病例中的这些数字相似。接种疫苗的病例住院治疗的比例略高(38%对30%)。因此,口服伤寒疫苗的使用不会改变沙门氏菌感染的临床病程。